Bonaccorso Joe's Form 4 filing
Verrica Pharmaceuticals Inc. (VRCA) · filed Aug 28, 2024
- Accession no.
- 0001415889-24-022425
- Filed
- Aug 28, 2024
- Trade date
- Aug 26-27, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $87.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bonaccorso JoeCIK 0001741973 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Common Stock | SSaleDisposed | −24,709 | $2.66 | −$65,725.94 | 82,107 | Direct | |
| Aug 27, 2024 | Common Stock | SSaleDisposed | −8,993 | $2.46 | −$22,122.78 | 73,114 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.